InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. We use disruptive technology to address unmet needs in the pain management and drug delivery markets.
View Top Employees from InSitu Biologics, Inc.Website | http://www.insitubiologics.com |
Revenue | $7 million |
Employees | 12 (12 on RocketReach) |
Founded | 2014 |
Address | 3510 Hopkins Pl N Building 4, Oakdale, Minnesota 55128, US |
Phone | (651) 337-4799 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Chemicals, Petrochemicals, Glass & Gases, Drug Delivery, Non-Opioid, Manufacturing, Science and Engineering, Sustained Release, Health Care, Pain Management, Therapeutics, Peri-Operative |
Competitors | Cellectar Biosciences, Inc., Co-D Therapeutics, Concortis Biosystems Corp, Melior Discovery, PRESCOS LLC |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular InSitu Biologics, Inc. employee's phone or email?
The InSitu Biologics, Inc. annual revenue was $7 million in 2024.
Kay Warnott is the Vice President, Clinical Operations and Regulatory Affairs of InSitu Biologics, Inc..
12 people are employed at InSitu Biologics, Inc..
InSitu Biologics, Inc. is based in Oakdale, Minnesota.
The NAICS codes for InSitu Biologics, Inc. are [3254, 32541, 325414, 32, 325].
The SIC codes for InSitu Biologics, Inc. are [28, 283].